See more : Cyber Enviro-Tech, Inc. (CETI) Income Statement Analysis – Financial Results
Complete financial analysis of Aeolus Pharmaceuticals, Inc. (AOLS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aeolus Pharmaceuticals, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Holders Technology plc (HDT.L) Income Statement Analysis – Financial Results
- Svenska Handelsbanken AB (publ) (SVNLY) Income Statement Analysis – Financial Results
- New Japan Chemical Co., Ltd. (4406.T) Income Statement Analysis – Financial Results
- Hopium SA (ALHPI.PA) Income Statement Analysis – Financial Results
- Rockhopper Exploration plc (RKH.L) Income Statement Analysis – Financial Results
Aeolus Pharmaceuticals, Inc. (AOLS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.aeoluspharma.com
About Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicants and nerve agents. The company is also developing AEOL 11114B, AEOL 11203, and AEOL 11207 for the treatment of Parkinson's disease, as well as AEOL 20415 for treating infectious diseases. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.08M | 3.11M | 9.63M | 3.93M | 7.29M | 4.82M | 0.00 | 0.00 | 0.00 | 0.00 | 92.00K | 252.00K | 305.00K | 0.00 | 86.00K | 44.00K | 100.00K | 2.10M | 6.10M | 4.00M | 5.00M |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.88M | 3.51M | 6.97M | 3.36M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.39M | -800.00K | -1.80M | -200.00K | -100.00K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -805.00K | -398.00K | 2.67M | 568.00K | 7.29M | 4.82M | 0.00 | 0.00 | 0.00 | 0.00 | 92.00K | 252.00K | 305.00K | 0.00 | 86.00K | 44.00K | -7.29M | 2.90M | 7.90M | 4.20M | 5.10M |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -38.78% | -12.79% | 27.67% | 14.46% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 0.00% | 100.00% | 100.00% | -7,285.00% | 138.10% | 129.51% | 105.00% | 102.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.88M | 3.51M | 6.97M | 3.36M | 6.47M | 5.06M | 1.69M | 711.00K | 977.00K | 1.38M | 3.48M | 4.52M | 8.30M | 2.78M | 7.63M | 7.52M | 0.00 | 19.00M | 16.80M | 14.70M | 2.30M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.47M | 2.23M | 2.70M | 3.27M | 3.20M | 3.67M | 1.95M | 1.29M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.47M | 2.23M | 2.75M | 3.27M | 3.20M | 3.67M | 1.95M | 1.29M | 1.54M | 1.92M | 2.22M | 2.67M | 3.99M | 2.03M | 2.82M | 3.08M | 2.61M | 3.00M | 3.50M | 2.10M | 1.90M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.35M | 5.74M | 9.71M | 6.63M | 9.66M | 8.72M | 3.64M | 2.00M | 2.52M | 3.30M | 5.70M | 7.19M | 12.28M | 4.81M | 10.45M | 10.60M | 2.87M | 22.80M | 22.10M | 17.00M | 4.30M |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.35M | 5.74M | 9.71M | 6.63M | 9.66M | 8.72M | 3.64M | 2.00M | 2.52M | 3.30M | 5.70M | 7.19M | 12.28M | 4.81M | 10.45M | 10.60M | 10.26M | 22.00M | 20.30M | 16.80M | 4.20M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.00K | 42.00K | 51.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 285.00K | 2.00K | 0.00 | 0.00 | 0.00 | 21.00K | 878.00K | 441.00K | 93.00K | 0.00 | 6.00K | 0.00 | 0.00 | 192.00K | 50.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K | 3.27M | 2.63M | 6.00K | 6.00K | 7.00K | 5.00K | 1.00K | -144.00K | 405.00K | -225.00K | 551.00K | 9.00K | 25.00K | 160.00K | 381.00K | 164.00K | 260.00K | 800.00K | 1.80M | 200.00K | 100.00K |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.27M | -2.63M | -80.00K | -2.69M | -2.36M | -8.12M | 17.70M | -2.15M | -2.11M | -3.53M | -5.05M | -6.93M | -11.95M | -4.87M | -6.32M | -7.93M | -9.90M | -19.11M | -12.38M | -18.00M | 800.00K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -157.66% | -84.41% | -0.83% | -55.55% | -88.21% | -168.41% | 0.00% | 0.00% | 0.00% | 0.00% | -5,492.39% | -2,774.21% | -3,926.23% | 0.00% | -11,780.23% | -25,861.36% | -13,391.00% | -928.57% | -122.95% | -367.50% | 2.00% |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.27M | -2.63M | -80.00K | -2.70M | -2.37M | -3.90M | -3.64M | -2.00M | -2.52M | -3.30M | -5.60M | -6.94M | -11.98M | -4.81M | -10.36M | -10.55M | -10.16M | -19.90M | -14.20M | -12.80M | 800.00K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -157.66% | -84.41% | -0.83% | -68.69% | -32.51% | -80.94% | 0.00% | 0.00% | 0.00% | 0.00% | -6,091.30% | -2,752.78% | -3,926.89% | 0.00% | -12,048.84% | -23,984.09% | -10,158.00% | -947.62% | -232.79% | -320.00% | 16.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -285.00K | -2.00K | 0.00 | -510.00K | 4.07M | 4.20M | -21.35M | 144.00K | -405.00K | 225.00K | -124.00K | 32.00K | -5.19M | 147.00K | -890.00K | -11.66M | 3.49M | 412.00K | -4.92M | 8.10M | 900.00K |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.56M | -2.63M | -80.00K | -3.21M | 1.70M | 320.00K | -24.99M | -1.86M | -2.92M | -3.08M | -5.72M | -6.87M | -11.95M | -4.66M | -11.25M | -22.21M | -6.67M | -19.50M | -19.10M | -10.70M | 1.60M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -171.39% | -84.47% | -0.83% | -81.67% | 23.28% | 6.64% | 0.00% | 0.00% | 0.00% | 0.00% | -6,219.57% | -2,727.78% | -3,919.34% | 0.00% | -13,083.72% | -50,484.09% | -6,665.00% | -928.57% | -313.11% | -267.50% | 32.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.27M | -2.63M | -6.00K | 510.00K | -4.07M | -4.20M | 22.23M | 437.00K | 51.00K | -51.00K | 6.00K | -32.00K | 5.19M | -1.91M | -100.00K | -990.00K | -3.49M | -300.00K | 4.90M | -2.70M | -400.00K |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.56M | -2.63M | -80.00K | -3.21M | 1.70M | 299.00K | -25.87M | -2.30M | -2.97M | -3.02M | -5.73M | -6.91M | -17.17M | -2.98M | -11.30M | -22.21M | -6.67M | -19.60M | -19.10M | -10.10M | 1.20M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -171.39% | -84.47% | -0.83% | -81.67% | 23.28% | 6.20% | 0.00% | 0.00% | 0.00% | 0.00% | -6,226.09% | -2,740.08% | -5,628.52% | 0.00% | -13,141.86% | -50,484.09% | -6,665.00% | -933.33% | -313.11% | -252.50% | 24.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 | 0.00 | -0.03 | 0.01 | 0.01 | -0.53 | -0.07 | -0.09 | -0.10 | -0.30 | -0.49 | -2.05 | -2.18 | -8.72 | -26.99 | -10.56 | -29.77 | -26.90 | -14.47 | 2.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 | 0.00 | -0.03 | -0.03 | 0.00 | -0.53 | -0.07 | -0.09 | -0.10 | -0.30 | -0.49 | -2.05 | -2.18 | -8.72 | -26.99 | -10.56 | -26.77 | -26.90 | -14.47 | 2.00 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 148.67M | 135.88M | 134.67M | 106.55M | 61.59M | 59.47M | 49.15M | 34.79M | 31.95M | 30.24M | 18.93M | 13.98M | 8.39M | 1.36M | 1.30M | 823.00K | 631.20K | 658.30K | 710.04K | 698.04K | 600.00K |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 148.67M | 135.88M | 134.67M | 106.55M | 71.04M | 85.86M | 49.15M | 34.79M | 32.22M | 30.24M | 18.93M | 13.98M | 8.39M | 1.36M | 1.30M | 823.00K | 631.20K | 732.14K | 710.04K | 698.04K | 600.00K |
Source: https://incomestatements.info
Category: Stock Reports